Vision Source Members – Our Dream is to Deliver on Your Dreams

For over 25 years, Optos has been Delivering on Dreams at Work with regard to ultra-widefield(UWF™) retinal imaging. And we will continue to deliver on our dream at work – enabling all Vision Source doctors to make optomap their primary choice for retinal imaging.

 

optomap is the ONLY:

• Single-capture 200° UWF retinal image
• UWF retinal imaging technology supported by 500+ clinical papers
• UWF retinal imaging product in over 1800 Vision Source practices

 

Connect with us at the Exchange, booth #701 or at one of our sessions listed below:


CE – Diabetes. Seeing is Believing. What Surprises Are In Store for You?

Wednesday, May 2
Doctors Jeffry Gerson and Laurie Sorrenson

______________________________________________________________________

Exhibit Theatre Sessions (limited to the first 32 guests)
Thursday, May 3
8:30 – 8:50pm
David Nelson, OD
optomap af – beyond color retinal imaging

 

Friday, May 4
11:30– 11:50am
Alex Martin, OD
Learn how your staff can affect acceptance and utilization of optomap in your practice

7:00 – 7:20pm
Brad Yates, VP of Product Management
Advance your knowledge of OptosAdvance image management and the key benefits of OptosCloud.

 
Saturday, May 5
12:30 – 12:50pm
Sharon Shepard, Director of Digital Marketing
Leverage the CustomerCentral portal to boost your practice further

______________________________________________________________________

 
Expanded Content Session
Optos Next Generation – Making Dreams a Reality
May 3, 2018
11:30 am – 12:20pm
Aaron Warner, OD, Nik London, MD

 

If you would like to learn more about how we can help your practice, please contact us.

 

Optos is a proud contributor to the Vision Source Foundation and a proud Diamond Sponsor of the Exchange®

 

Women (and Especially those Over 40) – It is Time to Pay Attention to Your Eye Health!

April is Women’s Eye Health and Safety Month, which may, at first glance, seem a bit of a niche concern. However, according to the organization Prevent Blindness, women make up the majority of the 4.4 million Americans, age 40 and older, who are visually impaired or blind.  More women than men have age-related macular degeneration, cataracts, and glaucoma.  These numbers will only continue to increase in the years to come.

Although there are no cures for some of these diseases, many of the effects may be lessened through early detection and treatment.  A 2015 survey found that one in four women had not received an eye exam in the past two years. Since women may not be aware that they are at greater risk than men of developing eye disease that could lead to serious vision impairment, practitioners can take the opportunity during Women’s Eye Health and Safety Month to stress the importance of paying attention to eye health and the importance of an annual eye exam.

A comprehensive eye exam should include a thorough examination of the retina, including an optomap, which is complementary to a DFE and an excellent tool for screening and for patient education. Because an optomap image can be obtained in less than ½ second, it leaves ample time for the practitioner to educate on eye health.

Click on image to read full story

Dr. Germain Burke and Britta

Dr. Germain Burke, of Burke Optometry in Lodi, California, understands the value of optomap in communicating with and educating her patients. She recounts a story about her patient, Britta, that demonstrates how an optomap screening can reveal issues in asymptomatic patients, as well as, patients who have trouble communicating or who may minimize health issues or concerns.

In July 2017, Britta made an appointment with Dr. Burke for a routine eye exam.  She did not share that she had been concerned about some vision distortion in her left eye.  However, Burke approached the exam as she would any routine visit, and fortunately for Britta, that included an optomap. The ultra-widefield digital retinal image provides a 200° view of the retina, out to the far periphery, and this .04 second capture revealed a large shadow OS.  Burke realized immediately that she was looking at a well-progressed melanoma.

“The melanoma was in the periphery but very clear.  It was a Friday afternoon so she took a picture of the optomap image on the screen and sent that immediately to her primary care physician through a secure portal.  Her PCP responded quickly and got her set up for a retinal exam on Monday.  On Tuesday she was in to see the oncologist and a PET scan, thankfully, showed that the cancer had not spread.”  A week later Britta had a radioactive plaque sewn into the sclera opposite the lesion and is now being monitored for efficacy and progression.

“I believe I am a good doctor but with optomap I feel like I am going to be able to catch big or small issues that I might not have seen otherwise.  I can provide more accurate notes and detailed information when I refer a patient on to a specialist. It facilitates the communication for follow-up care as well, and monitoring is more accurate,” says Burke.

She notes that they brought optomap technology into the practice shortly before she saw Britta, and stresses that this case is one of the reasons that she and the staff at Burke Optometry are glad that they did not wait to make that purchase. “Because we had that optomap image, the communication and the responsive action worked as smoothly and quickly as it possibly could have.  I really believe there was no other way it could have gone as well.  This is one of the reasons I sincerely feel everyone should have an optomap taken as part of a comprehensive exam.”

Visit our website to find a doctor such as Dr. Burke, who has optomap in their practice.

 

Doctor Discovers His Own Pathology with Proven UWF Technology

When Vince Young, OD introduced the Daytona from Optos in his practice, he volunteered to be the imaging guinea pig while his staff was being trained on the device.  He was unnerved when he reviewed his images with the trainer and somewhat uncertain about what he was actually seeing.  He knew what a posterior subcapsular cataract (PSC) looked like through the slit lamp but was surprised by what the optomap image laid evident.  While optomap is known for being able to penetrate through medial opacities far better than white light modalities, a PSC, which tends to be denser than other types of cataract, will cast a shadow on the retina revealing the issue. A concerned Dr. Young sent the image to his wife, Lindsey Brewer Young, OD.  When she reviewed the image on her phone she immediately responded, questioning whose eye she was regarding.  Learning it was her husband’s image she returned to the clinic, conducted a dilated exam, and confirmed that it was indeed a PSC that had been revealed in the optomap image.

Doctor discovers his own pathology with optomap

Read the entire story by clicking on the image

Young, who is 40, had no reason to suspect he would have cataracts which are more typically associated with the elderly population.  A subcapsular cataract occurs at the back of the lens and can be caused by a variety of circumstances such as systemic issues and some forms of medication. Posterior subscapsular cataracts are also more difficult to remove, due to adhesion of the cataract to the lens capsule, and there is an increased risk of capsule rupture during removal.1   However, Young’s cataract surgery on both eyes was successful and his vision is fine.

This discovery has become an excellent tool in communicating the importance of optomap to his patients.  The image hangs in the exam room while Young and his staff frequently share the story. “If the doctor didn’t know he had a cataract, how would anyone else know?” they say, underscoring how valuable the screening can be.  This unusual story has assisted with the elevated level of acceptance the optomap receives in the office.

Blanchard Eye Care sits in a quiet community outside Blanchard, OK and Young was concerned that he would have difficulty getting people in the rural community to embrace the technology.  He, however, was convinced that if he at least broke even it would be worth the investment based on the clinical value.  “Before purchasing the Daytona, I asked several of my colleagues about their experiences and they referred to it as a ‘no—brainer’,” says Young. He stresses that while the technology has without a doubt brought a financial bonus, the value of what it provides clinically far outweighs the monetary gain.

Young stresses how the exam experience has changed with optomap in an extremely valuable way when it comes to patient education.  The optomap image enables him to help his patients understand exactly what is occurring in their eye, or even just to provide reassurance that all is well.  “Even if there is no pathology, patients want me to take the images every year. They want to see what I see.”

Young happens to be color blind and further identifies another contribution that optomap brings to him, personally.  Because of this, a slit lamp view can sometimes make it difficult for him to distinguish between a hematoma and a nevus.  “However, the optomap image allows me to look at the different channels, and these features really jump out on some of the layers.  I’m much more positive about my diagnoses now.”

Dr. Young’s story demonstrates that it is not only possible for practitioners to image themselves and discover retinal pathology but also discover if significant opacities reside in the media as well.

Today, cataracts affect more than 22 million Americans age 40 and older. And as the US population ages, more than 30 million Americans are expected to have cataracts by the year 2020.2  optomap technology is being increasingly utilized in cataract surgery clinics for immediate views of the retina.  The ultra-widefield view is obtained through problematic, medial opacities, where white light has difficulty, revealing any retinal issues that might be a concern prior to surgery, as well as, following surgery. The ability to quickly and easily observe and document retinal health before and after cataract surgery provides both the patient and practitioner a tremendous peace of mind.

optomap, helping doctors identify pathology, even on themselves. Let us know if you are ready to bring optomap to your practice or clinic.

1http://optometrytimes.modernmedicine.com/optometrytimes/content/tags/cataract/types-cataracts-and-their-underlying-conditions?page=full

2 http://www.allaboutvision.com/conditions/cataracts.htm

 

Genetic Disorder Detected with optomap, Enhanced Patient Care, ProvenUWF

As a private practice optometric physician and professor of optometry near Portland, Oregon, Lorne Yudcovitch, OD had the opportunity to experience optomap technology on a frequent basis for nearly a decade, both in the clinical setting and as a tool for instructing his students. While he valued the ultra-widefield view and the innovative capabilities, he did not purchase an Optos device until 2012.

“I felt that the optomap technology had improved not only in resolution, but it was more user-friendly, making it much easier to position the patient – and we loved the autofluorescence modality. That has become really invaluable.” Yudcovitch explained how optomap Daytona can quickly and easily reveal issues that might otherwise go unnoticed.

He describes a recent scenario when Lila, a 54-year-old Caucasian female, came to the clinic with night vision complaints. Yudcovitch shares that she was correctable to 20/20 vision in each eye and that he found no retinal abnormalities with conventional imaging and ophthalmoscopy. However, the optomap af image revealed significant hyper and hypo fluorescence mottling in the posterior pole in both eyes. Yudcovitch immediately referred her for further retinal examination and genetic testing which revealed a hereditary PRPH2 gene mutation variant.

 

optomap image of Lila’s right eye

 

 

 

 

 

 

 

 

 

 

 

optomap af image of Lila’s right eye showing her genetic mutation

 

 

The gene product of PRPH2 is important to the integrity and stability of the structures that contain light-sensitive pigments. Slowly progressive loss of vision is typically seen in middle-aged individuals and the changes may be imperceptible initially, however, Autoflouresence can reveal abnormalities before patients become symptomatic.1 Yudcovitch acknowledges that optomap af was instrumental in the detection of the disease. Further genetic testing of the patient’s blood relatives was also recommended.

Prior to investing in optomap technology, Yudcovitch had relied on a retinal camera which was not utilized nearly as much because of the time and effort involved. The split-second, ease-of-use and dynamic modalities of optomap now enable them to image every patient in pre-test for documentation, as well as for detection of issues, like Lila’s, that could be otherwise missed.

Yudcovitch notes that patient response to the optomap experience has been favorable. “They find it extremely interesting and hi-tech. optomap has become very important in terms of patient education. It provides a good chronological assessment so that I can quickly and easily show my patients a side-by-side comparison and they can better understand what is occurring in their eyes. In fact, optomap has proven to be an excellent internal marketing tool because patients will often go and tell their family and friends about their experience and then these individuals start coming to see us.”

Ultimately, however, Yudcovitch places the greatest value on the enhanced quality of care for his patients. He emphasizes that optomap has helped the doctors at the practice to catch numerous sight and life-threatening pathologies from subtle hemorrhages and peripheral retinal tears to serious vascular issues and melanomas.

“Our Daytona is amazing. It does not replace what I do, but it enhances my abilities during the exam and that is invaluable. It’s definitely worth the cost and would move any practice to a higher level of care.”

As an eyecare professional, you may increase your practice efficiency and enhance patient care with optomap, just like Dr. Yudcovitch, and so many others. Contact us today to find out more.

1 http://disorders.eyes.arizona.edu/category/genes/prph2

Optos, Vision Expo East, Clinical Insights on AMD, and #ProvenUWF

Join Us at VEE

Join Us at VEE!

 

 

 

 

 

 

 

The leaders in ultra-widefield (UWF™) retinal imaging technology, Optos, invite you to join us at Vision Expo East (VEE) March 15–18 in NYC.

Find out what’s new at Optos by pre-scheduling your demonstration or stop by our booth. Learn about our devices, software and imaging modalities that can help you diagnose and treat more ocular and systemic disease.  Throughout the show, Optos will be at booth MS4849. Be our guest in the exhibit hall at VEE 2018 by clicking this link to receive your complimentary pass.

Getting in early? Join us, Thursday, March 15th at the Lambs Club at 6:30 pm for our Clinical Insights on AMD panel discussion, moderated by Dr. Jeff Gerson, FAAO.

Key topics include:
• The epidemiology of AMD and the global burden of the disease
• Combining traditional retinal exam methods with new technologies to facilitate early AMD detection
• How to customize treatment plans for patients with exudative and non-exudative AMD
• Implementing evidence-based nutritional management when appropriate
• The roles of macular pigment optical density testing, OCT, and dark adaptometry in building a retina/AMD practice

If you have any questions about our UWF retinal imaging or our offerings at VEE, please call 1-800-854-3039. We look forward to seeing you at the show!

Be sure to visit us at other upcoming events this spring!